(Q37902256)

25 August 2017

1 reference

title

Expression of microRNAs: potential molecular link between obesity, diabetes and cancer (English)

1 reference

25 August 2017

0 references

1 reference

1 reference

25 August 2017

A S Ali

1 reference

25 August 2017

S Ali

1 reference

25 August 2017

B Bao

1 reference

25 August 2017

P A Philip

1 reference

25 August 2017

F H Sarkar

1 reference

25 August 2017

publication date

19 July 2011

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

page(s)

1050-1062

1 reference

Exercise in weight management of obesity

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Adipokines: inflammation and the pleiotropic role of white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Cellular proliferation, apoptosis and angiogenesis: molecular targets for nutritional preemption of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Obesity, type 2 diabetes and risk of digestive cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Cellular metabolic stress: considering how cells respond to nutrient excess.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Aging and inflammation: etiological culprits of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Time course of risk factors in cancer etiology and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Sedentary Behavior and Cancer: A Systematic Review of the Literature and Proposed Biological Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Epidemiological aspects of neoplasms in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Diabetes and cancer: a consensus report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Impact of age, sex, and comorbidity on cancer therapy and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

New insulins and the risk of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Obesity, adipocytokines, and insulin resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Interaction between adiponectin and leptin influences the risk of colorectal adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

IL-1 family in breast cancer: potential interplay with leptin and other adipocytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

HNF1B and JAZF1 genes, diabetes, and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

miRBase: integrating microRNA annotation and deep-sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Meta-regulation: microRNA regulation of glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Role of microRNAs in obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Targeting microRNAs in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Role of microRNAs in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Identification of microRNAs with a role in glucose stimulated insulin secretion by expression profiling of MIN6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MicroRNAs in diabetes: tiny players in big disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Identification of microRNAs expressed highly in pancreatic islet-like cell clusters differentiated from human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Independent component and pathway-based analysis of miRNA-regulated gene expression in a model of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

The involvement of microRNAs in Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

microRNAs and cancer: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Targeting microRNAs in cancer: rationale, strategies and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

miRNAs and cancer: New research developments and potential clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Metastamir: the field of metastasis-regulatory microRNA is spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

A role of miR-27 in the regulation of adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MicroRNA and cancer--focus on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Role of anti-oncomirs miR-143 and -145 in human colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Patterns of known and novel small RNAs in human cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Downregulation of microRNAs-143 and -145 in B-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Decreased expression of microRNA-143 and -145 in human gastric cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Modulation of microRNA processing by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MicroRNA-143 Regulates Human Osteosarcoma Metastasis by Regulating Matrix Metalloprotease-13 Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Characterized mechanism of alpha-mangostin-induced cell death: caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Specific microRNAs modulate embryonic stem cell-derived neurogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Potential role of miR-9 and miR-223 in recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Expression profile of microRNAs in c-Myc induced mouse mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

New pancreas from old: microregulators of pancreas regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Expression of islet-specific microRNAs during human pancreatic development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

miR-335 directly targets Rb1 (pRb/p105) in a proximal connection to p53-dependent stress response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Endogenous human microRNAs that suppress breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Tumor angiogenesis: cause or consequence of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Abnormal angiogenesis in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

miR-200b Targets Ets-1 and Is Down-regulated by Hypoxia to Induce Angiogenic Response of Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Role of microRNAs in drug-resistant ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MicroRNAs in ovarian cancer biology and therapy resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

A pancreatic islet-specific microRNA regulates insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

miR-375 maintains normal pancreatic alpha- and beta-cell mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Systematic validation of predicted microRNAs for cyclin D1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

NF-kappaB signaling pathway and its therapeutic implications in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

NF-kappaB: a potential target for cancer chemoprevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Role of NF-kappa B in the pathogenesis of diabetes and its associated complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

NF-κB, inflammation, and metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

miR-146a suppresses invasion of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

microRNAs in Early Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Retracted: Up-Regulation of Sonic Hedgehog Contributes to TGF-β1-Induced Epithelial to Mesenchymal Transition in NSCLC Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

MiR-30 family and EMT in human fetal pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Evidence for epithelial-mesenchymal transition in adult human pancreatic exocrine cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Implication of microRNAs in drug resistance for designing novel cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Serum microRNAs as non-invasive biomarkers for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Diabetes mellitus type 2 - an independent risk factor for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Type 2 diabetes and cancer: what is the connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

10.1111/J.1467-789X.2011.00906.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference